Advertisement Roxane wins approval for Morphine sulfate tablets and oral solution - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Roxane wins approval for Morphine sulfate tablets and oral solution

Roxane Laboratories has received the FDA approval for its new drug application for Morphine sulfate tablets and oral solution CII.

Roxane Laboratories’s Morphine sulfate CII is available in 15mg, 30mg tablet strengths and 10mg/5ml, 20mg/5ml oral solution strengths. Roxane Laboratories’s Morphine sulfate tablets and oral solutions CII are currently available for immediate shipment to wholesalers and pharmacies nationwide.

With this new drug application approval, Roxane Laboratories has the only FDA approved Morphine sulfate immediate release tablets and oral solution available for distribution in the US.